Dagajas, Ashira Adiya P.
HRN: 21-35-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
07/09/2024
07/14/2024
PO
2.2ml
OD
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes